iRhythm Technologies

IRTC

Market cap $5.86B

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC). If you currently own shares of iRhythm stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=22399 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.com. Why Rosen.

New York, New York--(Newsfile Corp. - November 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC). If you currently own shares of Semtech Corporation stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=22399 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.co.

New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.

iRhythm Technologies stock has doubled this year.

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.

iRhythm Technologies Inc. (NASDAQ:IRTC) reported a third-quarter loss of 6 cents per share on Thursday, better than analysts' expectation of a 31-cent loss.

iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & Director Daniel Wilson - CFO & Principal Financial Officer Conference Call Participants Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division David Saxon - Needham & Company, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Stephanie Piazzola - BofA Securities, Research Division Max Kruszeski - William Blair & Company L.L.C.